Fragile X Syndrome CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. Fragile X Syndrome Gen Silencer sind erhältlich als Fragile X Syndrome CRISPR/Cas9 Knockout Plasmide und Fragile X Syndrome Double Nickase Plasmide. Fragile X Syndrome CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
Fragile X Syndrome CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
FXR1 CRISPR/Cas9 KO Plasmid (h) | sc-402570 | h | Gene Knockout | GFP | 0 | ||
FXR1 HDR Plasmid (h) | sc-402570-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FXR1 Double Nickase Plasmid (h) | sc-402570-NIC | h | Gene Knockout | Puromycin | 0 | ||
FXR1 Double Nickase Plasmid (h2) | sc-402570-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FXR1 CRISPR/Cas9 KO Plasmid (m) | sc-420430 | m | Gene Knockout | GFP | 0 | ||
FXR1 Double Nickase Plasmid (m) | sc-420430-NIC | m | Gene Knockout | Puromycin | 0 | ||
FXR1 Double Nickase Plasmid (m2) | sc-420430-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
FXR2 CRISPR/Cas9 KO Plasmid (h) | sc-406602 | h | Gene Knockout | GFP | 0 | ||
FXR2 HDR Plasmid (h) | sc-406602-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FXR2 Double Nickase Plasmid (h) | sc-406602-NIC | h | Gene Knockout | Puromycin | 0 | ||
FXR2 Double Nickase Plasmid (h2) | sc-406602-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FXR2 CRISPR/Cas9 KO Plasmid (m) | sc-423876 | m | Gene Knockout | GFP | 0 | ||
FXR2 HDR Plasmid (m) | sc-423876-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FXR2 Double Nickase Plasmid (m) | sc-423876-NIC | m | Gene Knockout | Puromycin | 0 | ||
FXR2 Double Nickase Plasmid (m2) | sc-423876-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Fragile X Syndrome CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
FXR1 CRISPR Activation Plasmid (h) | sc-402570-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 CRISPR Activation Plasmid (h2) | sc-402570-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 Lentiviral Activation Particles (h) | sc-402570-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 Lentiviral Activation Particles (h2) | sc-402570-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 CRISPR Activation Plasmid (m) | sc-420430-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 CRISPR Activation Plasmid (m2) | sc-420430-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 Lentiviral Activation Particles (m) | sc-420430-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR1 Lentiviral Activation Particles (m2) | sc-420430-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 CRISPR Activation Plasmid (h) | sc-406602-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 CRISPR Activation Plasmid (h2) | sc-406602-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 Lentiviral Activation Particles (h) | sc-406602-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 Lentiviral Activation Particles (h2) | sc-406602-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 CRISPR Activation Plasmid (m) | sc-423876-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 CRISPR Activation Plasmid (m2) | sc-423876-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 Lentiviral Activation Particles (m) | sc-423876-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FXR2 Lentiviral Activation Particles (m2) | sc-423876-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |